NewAmsterdam Pharma Company share price logo

NewAmsterdam Pharma Company

NASDAQ: NAMS

Mid Cap

$25.90

-0.89

(-3.32%)

as on

NewAmsterdam Pharma Company Stock Performance

as on August 29, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $25.53
    $26.88
    downward going graph

    1.43%

    Downside

    3.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $23.05
    $42.21
    downward going graph

    11.00%

    Downside

    62.95%

    Upside

    downward going graph

NewAmsterdam Pharma Company share price movements today

Previous Close
$26.79
Open
$26.66
Volume
983.4K
Market Cap
$3.1B
Day's Low - High
$25.53 - $26.88
52 Week Low - High
$23.05 - $42.21

NewAmsterdam Pharma Company Historical Returns

1 Month Return
-4.25 %
3 Month Return
-24.36 %
1 Year Return
+ 11.86 %
3 Year Return
+ 144.66 %
5 Year Return
0 %

NewAmsterdam Pharma Company Stock Fundamentals & Key Indicators

Check NewAmsterdam Pharma Company market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1B

EPS (TTM)

-1.6552

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-244.2M

Revenue (TTM)

7.1M

Profit Margin

0.00%

Return On Equity TTM

-36.81%

NewAmsterdam Pharma Company vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NewAmsterdam Pharma Company with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NewAmsterdam Pharma Company image
NewAmsterdam Pharma Company
BUY$3.1BNANA0.00%NA
Revolution Medicines image
Revolution Medicines
BUY$46.2B675.69%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$138.7B173.88%31.9286.04%NA
Moderna image
Moderna
BUY$59.7B-62.65%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for NewAmsterdam Pharma Company Stock including INR - Dollar returns

The NewAmsterdam Pharma Company stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

NewAmsterdam Pharma Company investment value today

Current value as on today

₹1,17,744

Returns

₹17,744

(+17.74%)

Returns from NewAmsterdam Pharma Company Stock

₹8,142 (+8.14%)

Dollar Impact

₹9,602 (+9.6%)

Analyst Recommendation on NewAmsterdam Pharma Company Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for NewAmsterdam Pharma Company. Average target price of $51.86

NewAmsterdam Pharma Company Share Price Target

Get share price movements and forecasts by analysts on NewAmsterdam Pharma Company.

What analysts predicted

50.06%UPSIDE

Target Price

$51.86

Current Price

$25.9

Analyzed by

9 Analysts

Target

$51.86

NewAmsterdam Pharma Company target price $51.86, a slight upside of 50.06% compared to current price of $25.9. According to 9 analysts rating.

Indian Investors' Interest in NewAmsterdam Pharma Company Stock

Search interest for NewAmsterdam Pharma Company Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

NewAmsterdam Pharma Company Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
2
32
12
2
19
0
0
3
3
Gross Profit
1
2
32
12
2
19
0
0
2
3
Operating Income
-55
-52
-25
-43
-68
-35
-55
-65
-58
-64
EBITDA
-93
-51
-23
-111
-39
-17
-71
-74
-48
-59
Interest Expense
0
0
1
3
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-93
-39
-16
-92
-39
-17
-72
-74
-48
-64
Income Tax Expense
-3
-12
0
-
-
-
-
-
-
-
Net Income
-101
-41
-18
-92
-39
-17
-72
-74
-48
-64
Net Profit Margin
-6692.86%
-1711.58%
-57.18%
-721.71%
-1327.30%
-90.70%
-20691.09%
-234134.38%
-1593.45%
-1732.91%

NewAmsterdam Pharma Company Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
108
15
45
22
Gross Profit
-
0
108
15
45
22
Operating Income
-6
-34
-3
-182
-176
-225
EBITDA
-6
-41
-22
-176
-241
-242
Interest Expense
0
0
0
6
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-7
-41
-22
-176
-241
-203
Income Tax Expense
0
0
70
0
0
-
Net Income
-8
-47
-23
-193
-241
-203
Net Profit Margin
0.00%
0.00%
-22.04%
-1255.76%
-530.25%
-905.74%

NewAmsterdam Pharma Company Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-39
-16
-92
-39
-17
39
-74
-48
-64
Operating Cash Flow
-53
-12
-37
-36
-37
-32
-40
-30
-39
Investing Cash Flow
0
0
-62
2
-159
2
-21
-11
-4
Financing Cash Flow
4
0
456
6
3
5
13
11
11
Change in Cash
-50
-7
349
-23
-184
-24
-48
-32
-33

NewAmsterdam Pharma Company Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-41
-22
-176
-241
-203
Operating Cash Flow
-29
10
-141
-158
-147
Investing Cash Flow
0
0
0
-62
-174
Financing Cash Flow
84
391
8
659
29
Change in Cash
50
407
-127
431
-280

Mutual Funds that own NewAmsterdam Pharma Company Stock

Check out the Mutual Funds with significant holdings in NewAmsterdam Pharma Company.

Funds
Holdings
Shares Held
SMALLCAP World Fund Inc
7.023823%
8396080
VANGUARD SPECIALIZED FUNDS
2.865906%
3425823
Fidelity Contrafund
1.308921%
1564648
Fidelity Rutland Square Trust II
1.224047%
1463192
Fidelity Select Portfolios
1.03106%
1232500
See all

Global Institutional Holdings in NewAmsterdam Pharma Company

Funds
Holdings
Peter Kolchinsky
7.99%
James E. Flynn
3.57%
Andreas Halvorsen
3.52%
Lee Ainslie
2.73%
Stanley Druckenmiller
2.57%
See all

Insights on NewAmsterdam Pharma Company

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 32.0K → 3.70M (in $), with an average increase of 58.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NAMS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 492.7% return, outperforming this stock by 481.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -48.44M → -64.13M (in $), with an average decrease of 32.4% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NAMS stock has moved down by -3.9%

About NewAmsterdam Pharma Company

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
OrganisationNewAmsterdam Pharma Company
HeadquartersGooimeer 2-35, Naarden, Netherlands, 1411 DC
IndustryBiotechnology
CEODr. Michael Harvey Davidson FACC, Facp., M.D.
E-voting on sharesClick here to vote

Key Management of NewAmsterdam Pharma Company

Name

Title

Dr. Michael Harvey Davidson FACC, Facp., M.D.

CEO, President & Executive Director

Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.

Founder, Chief Scientific Officer, Member of Executive Board & Director

Mr. Mayur Amrat Somaiya

Chief Financial Officer

FAQs

What is NewAmsterdam Pharma Company share price today?

NewAmsterdam Pharma Company share price today is $25.90 as on at the close of the market. NewAmsterdam Pharma Company share today touched a day high of $26.88 and a low of $25.53.

What is the 52 week high and 52 week low for NewAmsterdam Pharma Company share?

NewAmsterdam Pharma Company share touched a 52 week high of $42.21 on and a 52 week low of $23.05 on . NewAmsterdam Pharma Company stock price today i.e. is closed at $25.90,which is 38.63% down from its 52 week high and 12.36% up from its 52 week low.

What is NewAmsterdam Pharma Company's market capitalisation today?

NewAmsterdam Pharma Company market capitalisation is $0.00T as on .

How to invest in NewAmsterdam Pharma Company Stock (NAMS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NewAmsterdam Pharma Company on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NewAmsterdam Pharma Company Shares that will get you 0.0579 shares as per NewAmsterdam Pharma Company share price of $25.90 per share as on August 29, 2026 at 1:29 am IST.

What is the minimum amount required to buy NewAmsterdam Pharma Company Stock (NAMS) from India?

Indian investors can start investing in NewAmsterdam Pharma Company (NAMS) shares with as little as ₹95.368 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in NewAmsterdam Pharma Company stock (as per the Rupee-Dollar exchange rate as on ). Based on NewAmsterdam Pharma Company share’s latest price of $25.90 as on August 29, 2026 at 1:29 am IST, you will get 0.3861 shares of NewAmsterdam Pharma Company. Learn more about fractional shares .